Péter Ilonczai

Founder effect is responsible for the p.Leu131Phe heparin‐binding‐site antithrombin mutation common in Hungary: phenotype analysis in a large cohort

Réka Gindele, Zsolt Oláh, Péter Ilonczai et al. · Journal of Thrombosis and Haemostasis · 2016 · 59 citations · Full text

Phenotype Analysis, Genetics, Pathogenesis +8

Stem Cell Therapy: A Promising and Prospective Approach in the Treatment of Patients With Severe Buerger’s Disease

Z Boda, Miklós Udvardy, Katalin Rázsó et al. · Clinical and Applied Thrombosis/Hemostasis · 2008 · 25 citations

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center

Réka Gindele, Anna Selmeczi, Zsolt Oláh et al. · Thrombosis Research · 2017 · 24 citations · Full text

Thrombosis, Venous Thrombosis, Laboratory Hematology +14

Screening and monitoring of the <i>BTK</i>^C481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

Csaba Bödör, Lili Kotmayer, Tamás László et al. · British Journal of Haematology · 2021 · 21 citations · Full text

High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome

María Eugenia de la Morena‐Barrio, Réka Gindele, Carlos Bravo‐Pérez et al. · American Journal of Hematology · 2021 · 16 citations · Full text

Immunology, Vascular Malformation, Pathology +16